PubMed

A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.

Whitcup SM, Cantor LB, VanDenburgh AM, Chen K.

Br J Ophthalmol. 2003 Jan;87(1):57-62.PMID: 12488264 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial.

Brandt JD, VanDenburgh AM, Chen K, Whitcup SM; Bimatoprost Study Group.

Ophthalmology. 2001 Jun;108(6):1023-31; discussion 1032.PMID: 11382623 [PubMed - indexed for MEDLINE]Related articles

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure.

Sherwood M, Brandt J; Bimatoprost Study Groups 1 and 2.

Surv Ophthalmol. 2001 May;45 Suppl 4:S361-8.PMID: 11434939 [PubMed - indexed for MEDLINE]Related articles

Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.

Williams RD, Cohen JS, Gross RL, Liu CC, Safyan E, Batoosingh AL; Bimatoprost Study Group.

Br J Ophthalmol. 2008 Oct;92(10):1387-92. Epub 2008 Jul 11.PMID: 18621791 [PubMed - indexed for MEDLINE]Related articles

A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.

Coleman AL, Lerner F, Bernstein P, Whitcup SM.

Ophthalmology. 2003 Dec;110(12):2362-8.PMID: 14644719 [PubMed - indexed for MEDLINE]Related articles

One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension.

Higginbotham EJ, Schuman JS, Goldberg I, Gross RL, VanDenburgh AM, Chen K, Whitcup SM; Bimatoprost Study Groups 1 and 2.

Arch Ophthalmol. 2002 Oct;120(10):1286-93.PMID: 12365906 [PubMed - indexed for MEDLINE]Related articles

24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.

Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM; Bimatoprost Circadian IOP Study Group.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S26-35.PMID: 15016559 [PubMed - indexed for MEDLINE]Related articles

Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Easthope SE, Perry CM.

Drugs Aging. 2002;19(3):231-48. Review.PMID: 12027782 [PubMed - indexed for MEDLINE]Related articles

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group.

Am J Ophthalmol. 2003 Jan;135(1):55-63.PMID: 12504698 [PubMed - indexed for MEDLINE]Related articles

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension.

Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM; Bimatoprost Study Group 3.

Adv Ther. 2001 May-Jun;18(3):110-21.PMID: 11571823 [PubMed - indexed for MEDLINE]Related articles

Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension.

Goldberg I, Cunha-Vaz J, Jakobsen JE, Nordmann JP, Trost E, Sullivan EK; International Travoprost Study Group.

J Glaucoma. 2001 Oct;10(5):414-22.PMID: 11711841 [PubMed - indexed for MEDLINE]Related articles

Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management.

Laibovitz RA, VanDenburgh AM, Felix C, David R, Batoosingh A, Rosenthal A, Cheetham J.

Arch Ophthalmol. 2001 Jul;119(7):994-1000.PMID: 11448321 [PubMed - indexed for MEDLINE]Related articles

A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension.

Hommer A; Ganfort Investigators Group I.

Eur J Ophthalmol. 2007 Jan-Feb;17(1):53-62.PMID: 17294383 [PubMed - indexed for MEDLINE]Related articles

Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension.

Cohen JS, Gross RL, Cheetham JK, VanDenburgh AM, Bernstein P, Whitcup SM.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S45-52.PMID: 15016561 [PubMed - indexed for MEDLINE]Related articles

A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.

Manni G, Centofanti M, Parravano M, Oddone F, Bucci MG.

Graefes Arch Clin Exp Ophthalmol. 2004 Sep;242(9):767-70.PMID: 15241611 [PubMed - indexed for MEDLINE]Related articles

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Topouzis F, Melamed S, Danesh-Meyer H, Wells AP, Kozobolis V, Wieland H, Andrew R, Wells D.

Eur J Ophthalmol. 2007 Mar-Apr;17(2):183-90.PMID: 17415690 [PubMed - indexed for MEDLINE]Related articles

Bimatoprost/timolol fixed combination: a 3-month double-masked, randomized parallel comparison to its individual components in patients with glaucoma or ocular hypertension.

Brandt JD, Cantor LB, Katz LJ, Batoosingh AL, Chou C, Bossowska I; Ganfort Investigators Group II.

J Glaucoma. 2008 Apr-May;17(3):211-6.PMID: 18414107 [PubMed - indexed for MEDLINE]Related articles

Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial.

Fellman RL, Sullivan EK, Ratliff M, Silver LH, Whitson JT, Turner FD, Weiner AL, Davis AA; Travoprost Study Group.

Ophthalmology. 2002 May;109(5):998-1008.PMID: 11986110 [PubMed - indexed for MEDLINE]Related articles

Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.

Cantor LB, WuDunn D, Cortes A, Hoop J, Knotts S.

Surv Ophthalmol. 2004 Mar;49 Suppl 1:S12-8.PMID: 15016557 [PubMed - indexed for MEDLINE]Related articles

The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.

Barnebey HS, Orengo-Nania S, Flowers BE, Samples J, Mallick S, Landry TA, Bergamini MV.

Am J Ophthalmol. 2005 Jul;140(1):1-7.PMID: 15990081 [PubMed - indexed for MEDLINE]Related articles